Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Bishop

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Blood|January 15, 1994
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftM R Bishop, J R Anderson, J D Jackson, et al.
Bone Marrow Transplantation|March 30, 2004
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host diseaseM R Robinson, S S Lee, B I Rubin, et al.
Experimental Hematology|December 1, 1995
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.
Antisense Research and Development|January 1, 1993
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.
Lancet (London, England)|January 1, 1999
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantationR E Brand, J K DiBaise, E M Quigley, et al.
International Journal of Oncology|September 15, 1998
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cellsS S Joshi, N N Babushkina-Patz, D J Verbik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Cytotherapy|February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequencesH M Khuu, H Cowley, V David-Ocampo, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Blood|January 15, 1994
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftM R Bishop, J R Anderson, J D Jackson, et al.
Bone Marrow Transplantation|March 30, 2004
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host diseaseM R Robinson, S S Lee, B I Rubin, et al.
Experimental Hematology|December 1, 1995
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.
Antisense Research and Development|January 1, 1993
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.
Lancet (London, England)|January 1, 1999
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantationR E Brand, J K DiBaise, E M Quigley, et al.
International Journal of Oncology|September 15, 1998
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cellsS S Joshi, N N Babushkina-Patz, D J Verbik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Cytotherapy|February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequencesH M Khuu, H Cowley, V David-Ocampo, et al.
Pageof 8